BANJUL, The Gambia, April 16, 2021—Today, the World Bank Board approved $8 million additional financing from the International Development Association (IDA) to provide The Gambia with safe and effective vaccine purchase and deployment.
“With this additional financing, the World Bank is helping The Gambia strengthen their pandemic response and health care systems, as well as scale up its vaccination campaign, with a total contribution of $19 million towards the implementation of the Government’s National COVID-19 Preparedness and Response Plan,” said Feyi Boroffice, World Bank Resident Representative for The Gambia.
The additional financing for Gambia COVID-19 Vaccine Preparedness and Response Project will
strengthen immunization systems and service delivery capacity to support the COVID-19 vaccination roll-out. It will expand The Gambia’s access to vaccines, through direct purchases from manufacturers and other arrangements through the African Vaccine Acquisition Trust convened by the African Union.
“The COVAX Facility will provide vaccine doses to cover 480,000 people and this additional financing from the World Bank will make it possible to have sufficient vaccine doses to cover 980,000 more people, with nearly all adults in the Gambia having access,” said Samuel Mills, World Bank Task Team Leader for the project. “It is now important for people to be adequately informed that the benefits of COVID-19 vaccination
outweigh the risk of not getting the vaccine.”
To help prepare the National Deployment and Vaccination Plan for COVID-19 vaccines, the government conducted a vaccine readiness assessment with support from the World Bank, the World Health Organizations (WHO), the United Nation Children’s Fund (UNICEF) and the Global Alliance for Vaccines and Immunizations (GAVI). The assessment showed that the country has trained medical staff, a monitoring system in place, as well as adequate storage capacity to handle both routine vaccines and COVID -19 vaccine at temperatures between 2°C and 8°C. This additional financing will also support the procurement of ultracold freezers to augment the cold chain to store vaccines such as the Pfizer/BioNTech vaccine which require sub-zero storage, and the freezers will subsequently be used by the National Blood Transfusion Center for storing blood plasma.
In addition, the World Bank has supported the Ministry of Health in procuring innovative and environment friendly health care waste treatment technology to allow safe decontamination in hospitals. The Foundation Stone Laying Ceremony will be held tomorrow for the construction of clinical waste treatment centers at Farato and at Edward Francis Small Teaching Hospital. The project contributed to the renovation of the Ndemban Clinic, which operates as a COVID-19 treatment center, and procured 10 ambulances for intensive care, critical life-saving medical equipment and supplies, as well as six pickup trucks and 18 motorcycles to facilitate contact tracing and response.
This $8 million funding package for The Gambia is one of several projects in support for the COVID-19 vaccination effort across Africa and other regions. Today, the World Bank Board also approved additional financing for Côte d’Ivoire ($100 million), Eswatini ($5 million), Rwanda ($30 million), El Salvador ($50 million) and Honduras ($20 million).
World Bank Group COVID-19 Response
The World Bank, one of the largest sources of funding and knowledge for developing countries, is taking broad, fast action to help developing countries respond to the health, social and economic impacts of COVID-19. This includes $12 billion to help low- and middle-income countries purchase and distribute COVID-19 vaccines, tests, and treatments, and strengthen vaccination systems. The financing builds on the broader World Bank Group COVID-19 response, which is helping more than 100 countries strengthen health systems, support the poorest households, and create supportive conditions to maintain livelihoods and jobs for those hit hardest.
